The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashokkumar Barot
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Promoter Ashokkumar Vijaysinh Barot has disclosed an acquisition of 16,086 equity shares (0.04% of total share/voting capital) of Senores Pharmaceuticals Limited on August 22, 2025, through the open market. Following this purchase, his total holding stands at 34,43,866 shares, representing 7.48% of the company's share capital. The disclosure was filed under Regulation 29(2) of SEBI's SAST Regulations, 2011. The total equity share capital of the company remains 4,60,53,528 shares of ₹10 each before and after the acquisition.
This is a small open-market purchase by a promoter, indicating continued confidence in the company. Given the very small size (0.04%), it is unlikely to have any meaningful impact on the stock price, but signals promoter conviction.